Amphiphilic triblock copolymers containing Fe III -catecholate complexes formulated as spherical- or cylindrical-shaped micellar nanoparticles ( SMN and CMN , respectively) are described as new T 1 -weighted agents with high relaxivity, low cytotoxicity, and long-term stability in biological fl uids. Relaxivities of both SMN and CMN exceed those of established gadolinium chelates across a wide range of magnetic fi eld strengths. Interestingly, shape-dependent behavior is observed in terms of the particles’ interactions with HeLa cells, with CMN exhibiting enhanced uptake and contrast via magnetic resonance imaging (MRI) compared with SMN . These results suggest that control over soft nanoparticle shape will provide an avenue for optimization of particle-based contrast agents as biodiagnostics. The polycatechol nanoparticles are proposed as suitable for preclinical investigations into their viability as gadolinium-free, safe, and effective imaging agents for MRI contrast enhancement.

Polycatechol Nanoparticle MRI Contrast Agents

CARNIATO, FABIO;BOTTA, Mauro;
2016-01-01

Abstract

Amphiphilic triblock copolymers containing Fe III -catecholate complexes formulated as spherical- or cylindrical-shaped micellar nanoparticles ( SMN and CMN , respectively) are described as new T 1 -weighted agents with high relaxivity, low cytotoxicity, and long-term stability in biological fl uids. Relaxivities of both SMN and CMN exceed those of established gadolinium chelates across a wide range of magnetic fi eld strengths. Interestingly, shape-dependent behavior is observed in terms of the particles’ interactions with HeLa cells, with CMN exhibiting enhanced uptake and contrast via magnetic resonance imaging (MRI) compared with SMN . These results suggest that control over soft nanoparticle shape will provide an avenue for optimization of particle-based contrast agents as biodiagnostics. The polycatechol nanoparticles are proposed as suitable for preclinical investigations into their viability as gadolinium-free, safe, and effective imaging agents for MRI contrast enhancement.
File in questo prodotto:
File Dimensione Formato  
SMALL 2016.pdf

file disponibile solo agli amministratori

Tipologia: Versione Editoriale (PDF)
Licenza: DRM non definito
Dimensione 1.55 MB
Formato Adobe PDF
1.55 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11579/72887
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 66
  • ???jsp.display-item.citation.isi??? 67
social impact